None listed
Conditions
Interventions
Biological/Vaccine, Non-Stem Cell : Blood collection of 50cc, once
Periphieral blood mononuclear cells are isolated and the cells are expanded in culture using cytokines for 21 days to generate anti
Sponsors
The Catholic University of Korea, Seoul St. Mary's Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: For COVID-19 treated individuals: 1. Those who consent to the study 2. Aged 20 - to 65 years old 3. Individual who has been diagnosed with COVID-19 and released from quarantine, that is, the person who meets all the criteria for public release by the CDC: A. (clinical standard): no fever and no clinical symptoms B. (diagnostic criteria) PCR test results are negative twice every 24 hours For health donors: 1. Those who consent 2. Aged 20 to 65 years old 3. Those who do not have any fever or respiratory symptoms 4. Negative for Anti-SARS-CoV-2 Ab IgG antibodies
Exclusion criteria
Exclusion criteria: 1. Those who do not consent 2. Those under 20 or over 65 years of age 3. Positive for Anti-SARS-CoV-2 IgG antibodies 4. Positive for HIV, syphilis or hepatitis B and C carriers. 5. Those with any active infections requiring systemic medical treatment 6. Those who have been diagnosed with any other serious diseases
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cell number following culture of SARS-CoV-2 virus antigen peptide mixture treated peripheral nucleated cells;Fold expansion following culture of SARS-CoV-2 virus antigen peptide mixture treated peripheral nucleated cells | — |
Secondary
| Measure | Time frame |
|---|---|
| Characterization of cultured cells (Phenotypical analysis of cultured cells through flow cytometry) | — |
Countries
Korea, Republic of
Contacts
Public ContactJong Min Lee
The Catholic University of Korea, Seoul St. Mary's Hospital
Outcome results
None listed